2020
Association of socioeconomic status and molecular testing in stage IV colorectal cancer.
Punekar S, Griffin M, Masri L, Makarov D, Sherman S, Becker D. Association of socioeconomic status and molecular testing in stage IV colorectal cancer. Journal Of Clinical Oncology 2020, 38: e19023-e19023. DOI: 10.1200/jco.2020.38.15_suppl.e19023.Peer-Reviewed Original ResearchStage IV colorectal cancerKRAS testingColorectal cancerMedian household incomeMedicaid insuranceMolecular testingStage IV colorectal adenocarcinomaCox proportional hazards modelMultivariable logistic regression modelImpact of KRASAdvanced colorectal cancerEnd Results (SEER) databaseMajority of patientsRisk of deathEGFR monoclonal antibodyWild-type KRASProportional hazards modelLogistic regression modelsMedian survivalCRC patientsRectal cancerSurveillance EpidemiologyContemporary cohortDiagnosis yearResults database
2012
Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma
Friedberg J, Culligan M, Mick R, Stevenson J, Hahn S, Sterman D, Punekar S, Glatstein E, Cengel K. Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma. The Annals Of Thoracic Surgery 2012, 93: 1658-1667. PMID: 22541196, PMCID: PMC4394024, DOI: 10.1016/j.athoracsur.2012.02.009.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCohort StudiesCombined Modality TherapyDisease-Free SurvivalFemaleFollow-Up StudiesHumansImmunohistochemistryIntraoperative CareMaleMesotheliomaMiddle AgedNeoplasm InvasivenessNeoplasm Recurrence, LocalNeoplasm StagingPhotochemotherapyPleuraPleural NeoplasmsRisk AssessmentSurvival AnalysisTime FactorsTreatment OutcomeConceptsProgression-free survivalMacroscopic complete resectionRadical pleurectomyIntraoperative photodynamic therapyNonepithelial subtypeMedian survivalComplete resectionEpithelial subtypesStage III/IV diseaseMedian progression-free survivalStage III/IV cancerPhotodynamic therapyLung-sparing approachLung-sparing surgeryMalignant pleural mesotheliomaPostoperative mortalitySystemic therapyPleural mesotheliomaEpithelial diseasePatientsMesotheliomaSubtypesTherapyMonthsSurvival